1. ASN. Kidney disease: a growing public health and economic concern. http://www.asn-online.org/policy/webdocs/KD%20Growing%20Public%20Health%20Threat.pdf. Accessed July 10, 2014.
2. Clinicaltrials.gov. ESA agents. https://clinicaltrials.gov/ct2/results?term=ESA+agents&Search=Search. Accessed October 10, 2014.
3. New alternatives in anemia treatment: biosimilars and HIF stabilizers;Krishnan;Nephrol News,2014
4. HIF-based therapy. http://www.akebia.com/programs/. Accessed October 20, 2014.
5. Astellas news release. First patients enrolled in European phase III program. http://www.astellas.com/en/ir/pdf/4503Astellas_Roxadusutat.pdf. Accessed October 20, 2014.